Goodbody Health Limited (GDBYF) Research

Goodbody Health Inc. operates as a wellness enterprise, primarily offering a variety of health and well-being products and services throughout the United Kingdom. Furthermore, the company functions as a vertically integrated entity in the cannabinoid (CBD) sector, conducting its business across both the United Kingdom and the European Union. Its extensive operations encompass running COVID-19 and blood testing facilities, carrying out CBD extraction, engaging in the wholesale distribution of bulk CBD isolates and distillates, managing retail CBD sales and white-label provisions, conducting specialized cannabinoid laboratory analysis, and undertaking research initiatives in medicinal cannabis. The firm was previously known as Sativa Wellness Group Inc. before officially changing its name to Goodbody Health Inc. in January 2022. Its corporate headquarters are located in Vancouver, Canada.

Market snapshot

Symbol
GDBYF
Price
$0.00
Day change
0.00%
Market cap
$276.1
P/E ratio
-0.00x
52-week range
0.00001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acacia Diversified Holdings, Inc. (ACCA)
  • Acorda Therapeutics, Inc. (ACORQ)
  • Hempfusion Wellness Inc. (CBDHF)
  • Advanzeon Solutions, Inc. (CHCR)
  • Genesis Healthcare, Inc. (GENN)
  • Generex Biotechnology Corporation (GNBT)
  • MagForce AG (MGFRF)
  • Navidea Biopharmaceuticals, Inc. (NAVB)

Open Goodbody Health Limited (GDBYF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.